SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/F97A99B37D4300979DB266D64879B652604F4B3F746EB42600863EE50470F50B95001974F608EE0D4757846757FF5547>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/F97A99B37D4300979DB266D64879B652604F4B3F746EB42600863EE50470F50B95001974F608EE0D4757846757FF5547
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/F97A99B37D4300979DB266D64879B652604F4B3F746EB42600863EE50470F50B95001974F608EE0D4757846757FF5547
http://www.w3.org/2000/01/rdf-schema#comment
"TSP-1 is an important activator of TGF-beta in diabetic nephropathy in vivo and TSP-1-blocking therapies may be considered a promising future treatment option for diabetic nephropathy."
xsd:string
http://purl.uniprot.org/uniprot/#_DEE44486D39E7C260C68B36330C7C75A302DBE7BAA9380E6E5CF30345F94038430D4F2D81FBB51352044684CEE9A88D3
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/F97A99B37D4300979DB266D64879B652604F4B3F746EB42600863EE50470F50B95001974F608EE0D4757846757FF5547
http://purl.uniprot.org/uniprot/P35441
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/F97A99B37D4300979DB266D64879B652604F4B3F746EB42600863EE50470F50B95001974F608EE0D4757846757FF5547
http://purl.uniprot.org/uniprot/#_P35441-mappedCitation-17878288
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/F97A99B37D4300979DB266D64879B652604F4B3F746EB42600863EE50470F50B95001974F608EE0D4757846757FF5547